Purchases and Sales Made in Q3 2024 in Regeneron Pharmaceuticals, Inc. (REGN)
This table provides information about the institutional ownership of Regeneron Pharmaceuticals, Inc. (REGN) during Q3 2024. The information is specifically focused on institutions that hold shares of REGENERON PHARMACEUTICALS, INC..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2024
Q3 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-79.5K- 11.55% |
$81.5M - $95.6M
|
609K
$427M
|
|
Nov 14, 2024
Q3 2024
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-82.5K- 45.34% |
$84.5M - $99.1M
|
99.4K
$69.8M
|
|
Nov 14, 2024
Q3 2024
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
SELL
|
- |
-86K- 66.79% |
$88M - $103M
|
42.7K
$30M
|
|
Nov 12, 2024
Q3 2024
|
American Century Companies Inc
Kansas City, MO |
SELL
|
- |
-87.3K- 10.58% |
$89.4M - $105M
|
738K
$518M
|
|
Nov 14, 2024
Q3 2024
|
Ubs Asset Management Americas Inc
Chicago, IL |
SELL
|
- |
-92.6K- 10.92% |
$94.8M - $111M
|
755K
$530M
|
|
Nov 14, 2024
Q3 2024
|
Apg Asset Management N.V.
Amsterdam, P7 |
SELL
|
- |
-106K- 82.91% |
$108M - $127M
|
21.8K
$15.3M
|
|
Nov 14, 2024
Q3 2024
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-116K- 16.63% |
$118M - $139M
|
580K
$407M
|
|
Nov 12, 2024
Q3 2024
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-143K- 5.92% |
$147M - $172M
|
2.27M
$1.59B
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-156K- 11.62% |
$160M - $187M
|
1.19M
$832M
|
|
Nov 08, 2024
Q3 2024
|
Applied Finance Capital Management, LLC
San Juan, PR |
SELL
|
- |
-252K- 89.9% |
$258M - $302M
|
28.3K
$19.8M
|
|
Nov 13, 2024
Q3 2024
|
Capital World Investors
Los Angeles, CA |
SELL
|
- |
-340K- 7.34% |
$348M - $409M
|
4.3M
$3.02B
|
|
Nov 27, 2024
Q3 2024
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-343K- 15.31% |
$351M - $412M
|
1.9M
$1.33B
|
|
Nov 14, 2024
Q3 2024
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-621K- 58.5% |
$636M - $747M
|
441K
$309M
|
|
Nov 08, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-788K- 9.52% |
$807M - $947M
|
7.49M
$5.26B
|